Macro Dragon: Equities Divergence, Technical Check in on the divergence on AirBnB [ABNB], Compass Pathways [CMPS] & Beyond Meat [BYND] Macro Dragon: Equities Divergence, Technical Check in on the divergence on AirBnB [ABNB], Compass Pathways [CMPS] & Beyond Meat [BYND] Macro Dragon: Equities Divergence, Technical Check in on the divergence on AirBnB [ABNB], Compass Pathways [CMPS] & Beyond Meat [BYND]

Macro Dragon: Equities Divergence, Technical Check in on the divergence on AirBnB [ABNB], Compass Pathways [CMPS] & Beyond Meat [BYND]

Macro 4 minutes to read
Kay Van-Petersen

Global Macro Strategist

Summary:  Macro Dragon = Cross-Asset Quasi-Daily Views that could cover anything from tactical positioning, to long-term thematic investments, key events & inflection points in the markets, all with the objective of consistent wealth creation overtime.

(These are solely the views & opinions of KVP, & do not constitute any trade or investment recommendations. By the time you synthesize this, things may have changed.)

Macro Dragon: Technical Check-in on the Equities Divergences on AirBnB [ABNB], Compass Pathways [CMPS] & Beyond Meat [BYND]

Top of Mind…

  • As KVP gets back in the game, its been flagged by our world class Global Sales Trading Team - that we need more equity focus pieces for our clients... so we are just gonna check into three names that we've covered on the Macro Dragon before

  • As always, be wary of any equity analyst talking about equites, let alone the Macro Dude talking about equities... :)

  • Let’s start with the underperformer, BYND – which the Dragon has been covering for a whilst, since it actually listed. The Macro Skew on this was covered in Aug 2020; Erns Watch: Beyond Meat, Alternative Protein Theme & Macro Sins -  which touched on the Alternative Protein Space from a Meta Perspective.

  • KVP still has to catch-up with the latest fundamentals – previous quarter saw them continuing to invest in R&D & rebooting their European strategy, shifting from a partnership to driving it themselves. Next scheduled earnings date is after market on the Nov 10th

  • The chart & stock price has been ugly for the bulls & a delight for the bears – the 1Q spike was the GameStop/WSB/SME squeeze, followed by a similar smaller wave in the end of 2Q.

    BYND - 6m chart

  • Low for the year is $91.55 lvls, with key resistance likely being in the $120-130 range, from these $102 lvls. Its worth noting the short-interest as a % of the float is c. 28%, with c. 8x to cover as of 14 days ago. So we could see some shorts being covered as we approach the earnings date & a squeeze if there is an upbeat surprise. BYND has had 4 consecutive negative months where it has dropped from 157.49 to 98.98 for the close of Oct, that’s a -37% fall.

  • On the other hand, in just 1m alone Compass Pathways [CMPS] is up over +55%, in an example of where patience has paid off. We’ve touched on CMPS since its listing last year; Macro Dragon: Putting Compass on the Map... Mycelium, Magic Mushrooms + Psychedelics for Medicine & Treatment - with the key catalyst always being 2H21 on the results of the clinical trials.

    CMPS - 6m chart

  • The chart is breaking out big time past $40 previous resistance lvl. At $46.66, the next likely key lvls to test will be $50 & the all time high of c. $62. This is not a chart that KVP would be short, unless there was a specific event-driven catalyst as a play. Its worth noting that CMPS is set to report on Nov 12.

  • Lastly with at least no near-term earnings risk, we had AirBnB[ABNB] reporting yesterday, whilst it close dup +3.2% at 178.45, the results were post market & its currently looking indicated at 184.60/185.00, a c. +3-4% uplift on yest.’s close.

ABNB - 6m chart

  • The likely next key lvl to test on ABNB is $200, with support being offering at the $160 lvl. It will be interesting to see how it trades on this NFP Friday. Good wkd folks.


Start<>End = Gratitude + Integrity + Vision + Tenacity | Process > Outcome | Sizing > Position.

This is The Way



The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (
- Full disclaimer (

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.